Position in AMGN
as of Jun 30, 2026
· filed Aug 7, 2026
Position Value
$28,234,494
+$661,771 QoQ
Shares Held
77,970
-0.5% QoQ
Ownership
0.014%
of shares outstanding
% of Portfolio
0.18%
of 13F equity value
Holder Rank
#312
of 3,140 holders
Holding Since
Mar 2020
26 quarters on record
Voting authority
Sole 54%
Shared 0%
None 46%
Common Shares in AMGN Over Time
Shares Held
Position Value (USD)
Derivatives in AMGN
reported options exposure · as of Jun 30, 2026CallValue
$0
CallShares
0
PutValue
$1,484,692
PutShares
4,100
Notional value of option positions as reported on Form 13F. Calls and puts are disclosed separately and do not net against the common-share stake above.
Position in Drug Manufacturers - General
Healthcare · as of Jun 30, 2026Lido Advisors, LLC holds $485,897,181 across 15 Drug Manufacturers - General names. AMGN ranks #5 (5.8% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | LLY |
ELI LILLY & Co
|
114,252 | $137,037,286 | |
| 2 | ABBV |
AbbVie Inc.
|
459,683 | $115,674,628 | |
| 3 | JNJ |
Johnson & Johnson
|
392,685 | $99,730,207 | |
| 4 | MRK |
Merck & Co., Inc.
|
378,859 | $48,683,381 | |
| 5 | AMGN |
Amgen Inc
This page
|
77,970 | $28,234,494 | |
| 6 | GILD |
Gilead Sciences, Inc.
|
153,825 | $19,434,249 | |
| 7 | PFE |
Pfizer Inc
|
421,273 | $10,144,251 | |
| 8 | AZN |
Astrazeneca PLC
|
41,103 | $7,793,949 |
All Filings in AMGN
Export CSV
34 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $28,234,494 | 77,970 | Shares | Defined | 2026-08-07 | |
| 2026-06-30 | $1,484,692 | 4,100 | Put | Sole | 2026-08-07 | |
| 2026-03-31 | $27,572,723 | 78,365 | Shares | Defined | 2026-05-13 | |
| 2026-03-31 | $1,442,585 | 4,100 | Put | Sole | 2026-05-13 | |
| 2025-12-31 | $1,898,398 | 5,800 | Put | Sole | 2026-02-10 | |
| 2025-12-31 | $25,183,230 | 76,940 | Shares | Defined | 2026-02-10 | |
| 2025-09-30 | $21,959,674 | 77,816 | Shares | Sole | 2025-11-14 | |
| 2025-09-30 | $1,636,760 | 5,800 | Put | Sole | 2025-11-14 | |
| 2025-06-30 | $1,619,418 | 5,800 | Put | Sole | 2025-08-13 | |
| 2025-06-30 | $16,476,739 | 59,012 | Shares | Defined | 2025-08-13 | |
| 2025-03-31 | $1,464,285 | 4,700 | Put | Sole | 2025-05-15 | |
| 2025-03-31 | $17,922,223 | 57,526 | Shares | Defined | 2025-05-15 | |
| 2024-12-31 | $1,225,008 | 4,700 | Put | Sole | 2025-02-14 | |
| 2024-12-31 | $14,588,279 | 55,971 | Shares | Defined | 2025-02-14 | |
| 2024-09-30 | $16,275,469 | 50,512 | Shares | Sole | 2024-11-14 | |
| 2024-06-30 | $15,390,035 | 49,256 | Shares | Sole | 2024-08-15 | |
| 2024-03-31 | $20,999,305 | 73,858 | Shares | Defined | 2024-05-15 | |
| 2023-12-31 | $19,827,871 | 68,842 | Shares | Defined | 2024-02-14 | |
| 2023-09-30 | $17,686,288 | 65,807 | Shares | Sole | 2023-11-14 | |
| 2023-06-30 | $8,804,424 | 39,656 | Shares | Sole | 2023-08-09 | |
| 2023-03-31 | $9,201,487 | 38,062 | Shares | Defined | 2023-05-15 | |
| 2022-12-31 | $14,598,055 | 55,582 | Shares | Sole | 2023-02-14 | |
| 2022-12-31 | $210,112 | 800 | Put | Sole | 2023-02-14 | |
| 2022-09-30 | $7,451,047 | 33,057 | Shares | Defined | 2022-11-14 | |
| 2022-06-30 | $2,853,422 | 11,728 | Shares | Sole | 2022-08-15 | |
| 2022-03-31 | $3,175,096 | 13,130 | Shares | Sole | 2022-05-17 | |
| 2021-12-31 | $2,868,817 | 12,752 | Shares | Sole | 2022-02-15 | |
| 2021-09-30 | $9,231,136 | 43,410 | Shares | Sole | 2022-02-15 | |
| 2021-06-30 | $9,148,425 | 37,532 | Shares | Sole | 2021-08-12 | |
| 2021-03-31 | $8,697,402 | 34,956 | Shares | Sole | 2021-05-13 | |
| 2020-12-31 | $6,848,397 | 29,786 | Shares | Sole | 2021-02-08 | |
| 2020-09-30 | $2,177,388 | 8,567 | Shares | Sole | 2020-11-12 | |
| 2020-06-30 | $1,742,061 | 7,386 | Shares | Sole | 2020-08-12 | |
| 2020-03-31 | $1,302,134 | 6,423 | Shares | Sole | 2020-05-13 | |
| No filing history on record for this holder in this stock. | ||||||